600488 津药药业
已收盘 06-11 15:00:00
资讯
新帖
简况
津药药业:截至2026年6月10日,公司股东数为83,579户
证券之星 · 06-11 17:00
津药药业:截至2026年6月10日,公司股东数为83,579户
6月8日津药药业(600488)龙虎榜数据:北向资金净买入4797.97万元
证券之星 · 06-08
6月8日津药药业(600488)龙虎榜数据:北向资金净买入4797.97万元
6月8日津药药业(600488)涨停分析:创新药政策催化、研发布局深化驱动
证券之星 · 06-08
6月8日津药药业(600488)涨停分析:创新药政策催化、研发布局深化驱动
异动快报:津药药业(600488)6月8日9点42分触及涨停板
证券之星 · 06-08
异动快报:津药药业(600488)6月8日9点42分触及涨停板
每周股票复盘:津药药业(600488)将召开2025年度业绩说明会
证券之星 · 06-07
每周股票复盘:津药药业(600488)将召开2025年度业绩说明会
津药药业(600488.SH)拟收购津药物流100%股权 提质增效降低综合物流成本
智通财经网 · 06-05
津药药业(600488.SH)拟收购津药物流100%股权 提质增效降低综合物流成本
津药药业:截至2026年5月29日,公司股东数为80,693户
证券之星 · 06-02
津药药业:截至2026年5月29日,公司股东数为80,693户
每周股票复盘:津药药业(600488)子公司获贝美前列素滴眼液注册证
证券之星 · 05-31
每周股票复盘:津药药业(600488)子公司获贝美前列素滴眼液注册证
异动快报:津药药业(600488)5月29日10点44分触及涨停板
证券之星 · 05-29
异动快报:津药药业(600488)5月29日10点44分触及涨停板
津药药业(600488.SH)子公司贝美前列素滴眼液获得药品注册证书
智通财经 · 05-25
津药药业(600488.SH)子公司贝美前列素滴眼液获得药品注册证书
每周股票复盘:津药药业(600488)股价异动及控股股东拟变更
证券之星 · 05-24
每周股票复盘:津药药业(600488)股价异动及控股股东拟变更
津药药业(600488)披露股票交易异常波动公告,5月19日股价下跌4.91%
证券之星 · 05-19
津药药业(600488)披露股票交易异常波动公告,5月19日股价下跌4.91%
异动快报:津药药业(600488)5月18日9点32分触及跌停板
证券之星 · 05-18
异动快报:津药药业(600488)5月18日9点32分触及跌停板
每周股票复盘:津药药业(600488)周内三次登龙虎榜
证券之星 · 05-17
每周股票复盘:津药药业(600488)周内三次登龙虎榜
5月15日津药药业(600488)龙虎榜数据:北向资金净卖出897.54万元
证券之星 · 05-15
5月15日津药药业(600488)龙虎榜数据:北向资金净卖出897.54万元
异动快报:津药药业(600488)5月14日9点40分触及涨停板
证券之星 · 05-14
异动快报:津药药业(600488)5月14日9点40分触及涨停板
津药药业(600488)披露股票交易异常波动公告,5月13日股价下跌0.83%
证券之星 · 05-13
津药药业(600488)披露股票交易异常波动公告,5月13日股价下跌0.83%
5月12日津药药业(600488)龙虎榜数据:北向资金净卖出3867.87万元(3日)
证券之星 · 05-12
5月12日津药药业(600488)龙虎榜数据:北向资金净卖出3867.87万元(3日)
今日津药药业(600488)涨停分析:原料药出口、集采中标驱动
中金财经 · 05-12
今日津药药业(600488)涨停分析:原料药出口、集采中标驱动
今日津药药业(600488)涨停分析:集采中标、首仿落地、GMP认证驱动
证券之星 · 05-11
今日津药药业(600488)涨停分析:集采中标、首仿落地、GMP认证驱动
加载更多
公司概况
公司名称:
津药药业股份有限公司
所属行业:
医药制造业
上市日期:
2001-06-18
主营业务:
津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是地塞米松系列、泼尼松系列、甲泼尼龙系列、倍他米松系列、氨基酸、注射剂、软膏剂、乳膏剂、硬胶囊剂、丸剂、冻干粉针剂、吸入制剂、片剂。公司持续致力产品创新和技术革新,多次承担国家重大新药创制、国家重点研发计划等国家及省部级科研项目,荣获国家高新技术企业、天津市企业重点实验室、天津市企业技术中心、国家专利优秀奖、天津市科学技术进步奖特等奖、天津市先进级智能工厂、天津市绿色工厂等荣誉称号。
发行价格:
11.25
{"stockData":{"symbol":"600488","market":"SH","secType":"STK","nameCN":"津药药业","latestPrice":5.08,"timestamp":1781161200000,"preClose":5.23,"halted":0,"volume":98354300,"delay":0,"changeRate":-0.0287,"floatShares":1092000000,"shares":1092000000,"eps":0.0242,"marketStatus":"已收盘","change":-0.15,"latestTime":"06-11 15:00:00","open":5.25,"high":5.6,"low":5.05,"amount":513000000,"amplitude":0.1052,"askPrice":5.08,"askSize":416,"bidPrice":5.07,"bidSize":4035,"shortable":0,"etf":0,"ttmEps":0.0242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.23,"symbolType":"stock","openAndCloseTimeList":[[1781141400000,1781148600000],[1781154000000,1781161200000]],"highLimit":5.75,"lowLimit":4.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1091886680,"isCdr":false,"pbRate":1.82,"roa":"--","peRate":209.917355,"roe":"0.46%","epsLYR":0.065,"committee":0.53956,"marketValue":5547000000,"turnoverRate":0.0901,"status":1,"floatMarketCap":5547000000},"requestUrl":"/m/hq/s/600488","defaultTab":"news","newsList":[{"id":"2642140046","title":"津药药业:截至2026年6月10日,公司股东数为83,579户","url":"https://stock-news.laohu8.com/highlight/detail?id=2642140046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642140046?lang=zh_cn&edition=full","pubTime":"2026-06-11 17:00","pubTimestamp":1781168441,"startTime":"0","endTime":"0","summary":"证券之星消息,津药药业(600488)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年6月10日A股股东人数是多少?谢谢津药药业回复:投资者您好!截至2026年6月10日,公司股东数为83,579户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100026477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0102","600488","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641381483","title":"6月8日津药药业(600488)龙虎榜数据:北向资金净买入4797.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641381483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641381483?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:56","pubTimestamp":1780912616,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年6月8日公布的交易公开信息显示,津药药业因有价格涨跌幅限制的日收盘价格涨幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年6月8日收盘,津药药业报收于5.69元,上涨10.06%,涨停,换手率8.64%,成交量94.32万手,成交额5.22亿元。从龙虎榜公布的当日买卖数据来看,北向资金合计净买入4797.97万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800024703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0012","BK0028","BK0239","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641104810","title":"6月8日津药药业(600488)涨停分析:创新药政策催化、研发布局深化驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2641104810","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641104810?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:31","pubTimestamp":1780903883,"startTime":"0","endTime":"0","summary":"证券之星消息,津药药业6月8日涨停收盘,收盘价5.69元。该股于9点39分涨停,1次打开涨停,截止收盘封单资金为6818.27万元,占其流通市值1.1%。6月8日的资金流向数据方面,主力资金净流入2.27亿元,占总成交额43.53%,游资资金净流出9069.34万元,占总成交额17.36%,散户资金净流出1.37亿元,占总成交额26.17%。近5日资金流向一览见下表:该股为数字经济,化学原料药,医药概念热股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800014716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0239","BK0012","BK1161","BK0028","159992","BK0102","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641776181","title":"异动快报:津药药业(600488)6月8日9点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2641776181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641776181?lang=zh_cn&edition=full","pubTime":"2026-06-08 09:51","pubTimestamp":1780883467,"startTime":"0","endTime":"0","summary":"证券之星6月8日盘中消息,9点42分津药药业(600488)触及涨停板。其所属行业化学制药目前下跌。领涨股为津药药业。该股为辅助生殖,医药,化学原料药概念热股。6月5日的资金流向数据方面,主力资金净流出3670.54万元,占总成交额6.1%,游资资金净流出2657.16万元,占总成交额4.42%,散户资金净流入6327.7万元,占总成交额10.51%。近5日资金流向一览见下表:津药药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800003073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0239","600488","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641122472","title":"每周股票复盘:津药药业(600488)将召开2025年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122472","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122472?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:34","pubTimestamp":1780767252,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘,津药药业报收于5.17元,较上周的5.54元下跌6.68%。本周,津药药业6月1日盘中最高价报5.81元。津药药业当前最新总市值56.45亿元,在化学制药板块市值排名85/150,在两市A股市值排名3069/5206。本周关注点公司公告汇总:津药药业将于2026年6月10日召开2025年度业绩说明会。公司公告汇总津药药业股份有限公司将于2026年6月10日13:00-14:45通过上证路演中心召开2025年度业绩说明会,以视频直播和网络互动形式进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0102","BK0012","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641113722","title":"津药药业(600488.SH)拟收购津药物流100%股权 提质增效降低综合物流成本","url":"https://stock-news.laohu8.com/highlight/detail?id=2641113722","media":"智通财经网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641113722?lang=zh_cn&edition=full","pubTime":"2026-06-05 15:54","pubTimestamp":1780646079,"startTime":"0","endTime":"0","summary":"智通财经APP讯,津药药业(600488.SH)发布公告,公司拟以现金支付方式收购天津药业集团有限公司持有的津药物流(天津)有限公司(简称“津药物流”)100%股权,交易对价为1.3亿元。交易前,公司未持有津药物流股权,此次收购完成后,津药物流将成为公司全资子公司,能够有效整合物流体系,完善公司全产业链布局,进一步提升仓储配送、管理效率。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"津药药业(600488.SH)拟收购津药物流100%股权 提质增效降低综合物流成本","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0028","600488","BK0239","BK0102","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640694916","title":"津药药业:截至2026年5月29日,公司股东数为80,693户","url":"https://stock-news.laohu8.com/highlight/detail?id=2640694916","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640694916?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:51","pubTimestamp":1780390289,"startTime":"0","endTime":"0","summary":"证券之星消息,津药药业(600488)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年5月29日A股股东人数是多少?谢谢津药药业回复:投资者您好!截至2026年5月29日,公司股东数为80,693户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200031589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0239","BK0028","BK0012","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601677","title":"每周股票复盘:津药药业(600488)子公司获贝美前列素滴眼液注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601677","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639601677?lang=zh_cn&edition=full","pubTime":"2026-05-31 01:25","pubTimestamp":1780161912,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,津药药业报收于5.54元,较上周的5.42元上涨2.21%。本周,津药药业5月29日盘中最高价报5.54元。本周共计1次涨停收盘,无跌停收盘情况。津药药业当前最新总市值60.49亿元,在化学制药板块市值排名82/150,在两市A股市值排名2927/5207。该药品用于降低开角型青光眼及高眼压症患者的眼压。津药和平已累计投入研发费用约1,793.48万元。2024年、2025年国内销售额分别为1,862万元、1,669万元。本次获批有助于完善公司制剂产品群,拓展眼科领域产品管线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","BK0102","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639064342","title":"异动快报:津药药业(600488)5月29日10点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2639064342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639064342?lang=zh_cn&edition=full","pubTime":"2026-05-29 10:45","pubTimestamp":1780022718,"startTime":"0","endTime":"0","summary":"证券之星5月29日盘中消息,10点44分津药药业(600488)触及涨停板。其所属行业化学制药目前下跌。领涨股为德展健康。该股为辅助生殖,医药,化学原料药概念热股。5月28日的资金流向数据方面,主力资金净流入631.77万元,占总成交额1.64%,游资资金净流入1685.58万元,占总成交额4.38%,散户资金净流出2317.35万元,占总成交额6.02%。近5日资金流向一览见下表:津药药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900014969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","BK0102","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638274533","title":"津药药业(600488.SH)子公司贝美前列素滴眼液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2638274533","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638274533?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:36","pubTimestamp":1779694615,"startTime":"0","endTime":"0","summary":"智通财经APP讯,津药药业(600488.SH)发布公告,近日,公司子公司津药和平(天津)制药有限公司收到国家药品监督管理局核准签发的贝美前列素滴眼液的《药品注册证书》。据悉,贝美前列素滴眼液用于降低开角型青光眼及高眼压症患者的眼压。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"津药药业(600488.SH)子公司贝美前列素滴眼液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600488","BK0239","BK0012","BK0028","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637378143","title":"每周股票复盘:津药药业(600488)股价异动及控股股东拟变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2637378143","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637378143?lang=zh_cn&edition=full","pubTime":"2026-05-24 01:32","pubTimestamp":1779557531,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,津药药业报收于5.42元,较上周的7.01元下跌22.68%。本周,津药药业5月18日盘中最高价报6.47元。来自公司公告汇总:津药药业间接控股股东上海琉璃光拟被公开征集受让方。来自公司公告汇总:津药药业一季度归母净利润1389.13万元,同比下降76.07%。津药药业于2026年5月19日收到相关通知。津药药业股票于2026年5月15日、5月18日、5月19日连续三个交易日收盘价格跌幅偏离值累计达20%,构成交易异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","600488","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636520148","title":"津药药业(600488)披露股票交易异常波动公告,5月19日股价下跌4.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636520148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636520148?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:24","pubTimestamp":1779200660,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,津药药业报收于6.0元,较前一交易日下跌4.91%,最新总市值为65.51亿元。近日,津药药业股份有限公司发布《股票交易异常波动公告》。公告显示,公司股票于2026年5月15日、5月18日、5月19日连续三个交易日内日收盘价格跌幅偏离值累计达到20%,构成股票交易异常波动。公司2026年第一季度营业收入6.08亿元,同比下降22.61%;归母净利润1389.13万元,同比下降76.07%。董事会确认无应披露未披露事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900043940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0102","BK0012","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636048869","title":"异动快报:津药药业(600488)5月18日9点32分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2636048869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636048869?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:37","pubTimestamp":1779068244,"startTime":"0","endTime":"0","summary":"证券之星5月18日盘中消息,9点32分津药药业(600488)触及跌停板。其所属行业化学制药目前下跌。领涨股为司太立。该股为数字经济,辅助生殖,新冠病毒防治概念热股。5月15日的资金流向数据方面,主力资金净流出1.14亿元,占总成交额40.11%,游资资金净流入2705.84万元,占总成交额9.52%,散户资金净流入8699.14万元,占总成交额30.59%。近5日资金流向一览见下表:津药药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800005203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","600488","BK0012","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636724069","title":"每周股票复盘:津药药业(600488)周内三次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2636724069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636724069?lang=zh_cn&edition=full","pubTime":"2026-05-17 01:25","pubTimestamp":1778952310,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,津药药业报收于7.01元,较上周的6.0元上涨16.83%。本周,津药药业5月14日盘中最高价报7.92元。来自公司公告汇总:津药药业2025年年度股东会顺利召开,审议通过利润分配等议案,并选举毕晓方为独立董事。交易信息汇总津药药业于2026年5月15日因日收盘价格跌幅偏离值达7%登上龙虎榜,为近5个交易日内第3次上榜。公司公告汇总津药药业股票于2026年5月11日、5月12日连续两日收盘价格涨幅偏离值累计达20%,构成异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0102","BK0239","BK0028","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635707713","title":"5月15日津药药业(600488)龙虎榜数据:北向资金净卖出897.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635707713","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635707713?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:27","pubTimestamp":1778837224,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年5月15日公布的交易公开信息显示,津药药业因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年5月15日收盘,津药药业报收于7.01元,下跌10.01%,跌停,换手率3.68%,成交量40.2万手,成交额2.84亿元。从龙虎榜公布的当日买卖数据来看,北向资金合计净卖出897.54万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500031538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","600488","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635698763","title":"异动快报:津药药业(600488)5月14日9点40分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2635698763","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635698763?lang=zh_cn&edition=full","pubTime":"2026-05-14 09:45","pubTimestamp":1778723128,"startTime":"0","endTime":"0","summary":"证券之星5月14日盘中消息,9点40分津药药业(600488)触及涨停板。其所属行业化学制药目前上涨。领涨股为昂利康。该股为辅助生殖,医药,化学原料药概念热股,当日辅助生殖概念上涨0.06%。5月13日的资金流向数据方面,主力资金净流出1.09亿元,占总成交额5.49%,游资资金净流入1205.37万元,占总成交额0.61%,散户资金净流入9655.69万元,占总成交额4.88%。近5日资金流向一览见下表:津药药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400011117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600488","BK0012","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635207167","title":"津药药业(600488)披露股票交易异常波动公告,5月13日股价下跌0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635207167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635207167?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:33","pubTimestamp":1778664788,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘,津药药业报收于7.2元,较前一交易日下跌0.83%,最新总市值为78.62亿元。津药药业股份有限公司于近日披露《股票交易异常波动公告》。公告显示,公司股票于2026年5月11日、5月12日连续两个交易日内日收盘价格涨幅偏离值累计达到20%,构成股票交易异常波动。经公司自查并书面征询控股股东,截至公告披露日,公司及控股股东不存在应披露而未披露的重大事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300032100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0102","BK0012","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634294441","title":"5月12日津药药业(600488)龙虎榜数据:北向资金净卖出3867.87万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634294441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634294441?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:27","pubTimestamp":1778578025,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年5月12日公布的交易公开信息显示,津药药业因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年5月12日收盘,津药药业报收于7.26元,上涨10.0%,已连续涨停2天,换手率19.73%,成交量215.47万手,成交额14.88亿元。从龙虎榜公布的三日买卖数据来看,北向资金合计净卖出3867.87万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200029656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0102","BK0028","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634295302","title":"今日津药药业(600488)涨停分析:原料药出口、集采中标驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634295302","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634295302?lang=zh_cn&edition=full","pubTime":"2026-05-12 15:48","pubTimestamp":1778572109,"startTime":"0","endTime":"0","summary":"证券之星消息,津药药业5月12日涨停收盘,收盘价7.26元。今日津药药业涨停的可能因素有:市场持续炒作‘甾体激素+原料药出口’题材,虽公司多次澄清无在研创新药、纯属误读;叠加10个品种拟中选国家集采、二氟泼尼酯滴眼液等首仿产品通过GMP认证、出口创汇1.29亿美元且外销占比约32%等实质性业务支撑;公司坚持‘原料药+制剂’一体化战略,地塞米松、泼尼松等70余个原料药品种覆盖全球70余国,基本面边际改善信号被资金阶段性聚焦。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/12/20260512601321.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/12/20260512601321.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260512/32217762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","600488","BK0102","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634405585","title":"今日津药药业(600488)涨停分析:集采中标、首仿落地、GMP认证驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634405585","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634405585?lang=zh_cn&edition=full","pubTime":"2026-05-11 15:36","pubTimestamp":1778485004,"startTime":"0","endTime":"0","summary":"证券之星消息,津药药业5月11日涨停收盘,收盘价6.6元。今日津药药业涨停的可能因素有:12个产品中选国家集采,采购周期至2028年,锁定三年稳定销售;二氟泼尼酯滴眼液等首仿新品获批落地,填补眼科激素制剂空白;激素类滴眼剂、小容量注射剂等多条产线通过GMP认证,新增产能8500万支/年;公司坚持‘原料药+制剂’一体化战略,甾体激素原料药出口覆盖70余国,获美国DMF认证;90.8亿元银行授信强化运营保障能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100015339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","BK0012","BK0028","600488"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781199463938,"stockEarnings":[{"period":"1week","weight":-0.0696},{"period":"1month","weight":-0.3003},{"period":"3month","weight":0.2038},{"period":"6month","weight":0.2421},{"period":"1year","weight":0.1891},{"period":"ytd","weight":0.2421}],"compareEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":-0.054},{"period":"3month","weight":-0.0265},{"period":"6month","weight":0.0251},{"period":"1year","weight":0.1719},{"period":"ytd","weight":0.0046}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"津药药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"83579人(较上一季度增加3.58%)","perCapita":"13064股","listingDate":"2001-06-18","address":"天津市东丽区开发区西区新业九街19号","registeredCapital":"109188万元","survey":" 津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是地塞米松系列、泼尼松系列、甲泼尼龙系列、倍他米松系列、氨基酸、注射剂、软膏剂、乳膏剂、硬胶囊剂、丸剂、冻干粉针剂、吸入制剂、片剂。公司持续致力产品创新和技术革新,多次承担国家重大新药创制、国家重点研发计划等国家及省部级科研项目,荣获国家高新技术企业、天津市企业重点实验室、天津市企业技术中心、国家专利优秀奖、天津市科学技术进步奖特等奖、天津市先进级智能工厂、天津市绿色工厂等荣誉称号。","listedPrice":11.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"津药药业,600488,津药药业股票,津药药业股票老虎,津药药业股票老虎国际,津药药业行情,津药药业股票行情,津药药业股价,津药药业股市,津药药业股票价格,津药药业股票交易,津药药业股票购买,津药药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}